首页> 外文期刊>BMC Nephrology >Your Path to Transplant: a randomized controlled trial of a tailored computer education intervention to increase living donor kidney transplant
【24h】

Your Path to Transplant: a randomized controlled trial of a tailored computer education intervention to increase living donor kidney transplant

机译:您的移植道路:一项量身定制的计算机教育干预的随机对照试验,以增加生活供体肾移植

获取原文
           

摘要

Background Because of the deceased donor organ shortage, more kidney patients are considering whether to receive kidneys from family and friends, a process called living donor kidney transplantation (LDKT). Although Blacks and Hispanics are 3.4 and 1.5 times more likely, respectively, to develop end stage renal disease (ESRD) than Whites, they are less likely to receive LDKTs. To address this disparity, a new randomized controlled trial (RCT) will assess whether Black, Hispanic, and White transplant patients’ knowledge, readiness to pursue LDKT, and receipt of LDKTs can be increased when they participate in the Your Path to Transplant (YPT) computer-tailored intervention. Methods/Design Nine hundred Black, Hispanic, and White ESRD patients presenting for transplant evaluation at University of California, Los Angeles Kidney and Pancreas Transplant Program (UCLA-KPTP) will be randomly assigned to one of two education conditions, YPT or Usual Care Control Education (UC). As they undergo transplant evaluation, patients in the YPT condition will receive individually-tailored telephonic coaching sessions, feedback reports, video and print transplant education resources, and assistance with reducing any known socioeconomic barriers to LDKT. Patients receiving UC will only receive transplant education provided by UCLA-KPTP. Changes in transplant knowledge, readiness, pros and cons, and self-efficacy to pursue LDKT will be assessed prior to presenting at the transplant center (baseline), during transplant evaluation, and 4- and 8-months post-baseline, while completion of transplant evaluation and receipt of LDKTs will be assessed at 18-months post-baseline. The RCT will determine, compared to UC, whether Black, Hispanic, and White patients receiving YPT increase in their readiness to pursue LDKT and transplant knowledge, and become more likely to complete transplant medical evaluation and pursue LDKT. It will also examine how known patient, family, and healthcare system barriers to LDKT act alone and in combination with YPT to affect patients’ transplant decision-making and behavior. Statistical analyses will be performed under an intent-to-treat approach. Discussion At the conclusion of the study, we will have assessed the effectiveness of an innovative and cost-effective YPT intervention that could be utilized to tailor LDKT discussion and education based on the needs of individual patients of different races in many healthcare settings. Trial registration ClinicalTrials.gov, number NCT02181114 .
机译:背景由于死者的捐赠器官短缺,更多的肾患者正在考虑是否接受来自家人和朋友的肾脏,这是一种叫做活体肾移植(LDKT)的过程。虽然黑人和西班牙裔分别比白人开发结束阶段肾病(ESRD),但是,虽然黑人和西班牙裔人数分别为3.4和1.5倍,但它们不太可能收到LDKTS。为了解决这种差异,新的随机对照试验(RCT)将评估黑色,西班牙裔和白色移植患者的知识,准备追求LDKT,并在参加移植路径时可以增加和收到LDKTS(YPT )计算机量身定制的干预。方法/设计九百黑色,西班牙裔和白色ESRD患者在加州大学的移植评估,洛杉矶肾脏和胰腺移植计划(UCLA-KPTP)将随机分配给两个教育条件,YPT或通常的护理控制之一教育(UC)。随着他们进行移植评估,患者在凯茨条件下将收到单独量身定制的电话指导会议,反馈报告,视频和打印移植教育资源,以及减少任何已知的社会经济障碍到LDKT。接受UC的患者只接受UCLA-KPTP提供的移植教育。在移植中心(基线),在移植评估期间,在移植中心(基线)之前,将在移植中心(基线),并在基线后4-个月,完成后,将在移植中心(基线)的变化以及追求LDKT的变化。将在基线后18个月评估移植评估和收到LDKTS。与UC相比,RCT将确定,无论是黑色,西班牙裔和白色患者是否均衡遵循其准备就绪和移植知识,并变得更加可能完成移植医学评估和追求LDKT。它还将研究知名的患者,家庭和医疗保健系统障碍单独行动,并与YPT结合影响患者的移植决策和行为。将根据意图的方法进行统计分析。在该研究结束时讨论,我们将评估创新和成本效益的YPT干预的有效性,这些干预可用于根据许多医疗环境中不同种族患者的需求来定制LDKT讨论和教育。试验登记ClinicalTrials.gov,NCT02181114号码。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号